The link between diabetes mellitus and Alzheimer's disease (AD) has been known for the
last few decades. Since insulin and insulin receptors are known to be present in the brain …

The current understanding of neurodegenerative processes in sporadic diseases such as
Alzheimer's disease (AD), Parkinson's disease (PD) or multiple sclerosis is very limited …

Dementia is a chronic, irreversible condition marked by memory loss, cognitive decline, and
mental instability. It is clinically related to various progressive neurological diseases …

Type 2 diabetes has been identified as a risk factor for Alzheimer's disease (AD). The
underlying mechanism behind this unexpected link is most likely linked to the observed …

Introduction: Epidemiological evidence suggests an association between type 2 diabetes
(T2DM) and Alzheimer's disease (AD), in that one disease increases the risk of the other …

The current absence of effective treatments for Alzheimer's disease (AD) and Parkinson's
disease (PD) reflects an incomplete knowledge of the underlying disease processes …

Type 2 diabetes has been identified as a risk factor for patients with Alzheimer's disease.
Insulin signalling is often impaired in Alzheimer's disease, contributing to the …

Alzheimer's disease (AD) is a progressive neurodegenerative disorder, accompanied by
memory loss and cognitive impairments, and there is no effective treatment for it at present …

The incretin hormone glucagon-like peptide 1 (GLP-1) has many effects in the body. It is best
known for the 'incretin effect', facilitating insulin release from the pancreas under …

Type 2 diabetes mellitus and the associated desensitisation of insulin signalling has been
identified as a risk factor for progressive neurodegenerative disorders such as Alzheimer's …